Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072. (Q39890804)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

uterine sarcoma

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Charlotte Benson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Isabelle Ray-Coquard

2

object named as

I Ray-Coquard

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

author name string

S Sleijfer

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

S Litière

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

A Le Cesne

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Z Papai

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

I Judson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

P Schöffski

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

S Chawla

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

T Gil

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

S Piperno-Neumann

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

S Marréaud

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

M R Dewji

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

W T A van der Graaf

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

language of work or name

0 references

publication date

29 April 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

142

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

89-94

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Hormonal treatments in metastatic endometrial stromal sarcomas: the 10-year experience of the sarcoma unit of Royal Marsden Hospital

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Phase I trial of pazopanib in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

PDGFR-alpha as a potential therapeutic target in uterine sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.024

7 January 2021

Identifiers

10.1016/J.YGYNO.2016.03.024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27012429%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39890804&oldid=2092179118"